NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/31/2024
Back to search
Official data from USPTO
PINETREE THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
PINETREE THERAPEUTICS
ST13
US500000090534257Class
42, 44
Filing
90534257
Registration
7634072
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
12/31/2024
Classification
Registered
Trademark type
Word
Nice classes
42, 44
Filing date
02/18/2021
Registration date
12/31/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/31/2024
Last transaction
12/31/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/31/2019
First use in commerce
12/31/2019
Drawing code
4
Owner type
03
Owner location
Cambridge, MA, US
Examiner
KUHN, RIO NICE
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Pinetree Therapeutics, Inc.
Representatives
Kongsik Kim United One Law Group LLC
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development of pharmaceuticals for others; Research and development of pharmaceuticals for others related to cancerinfectious diseasesviral related diseases and disorders; Medical research; Medical laboratories; Medical and scientific research in the field of cancerinfectious diseasesviral related diseases and disorders; Clinical research in the field of cancerinfectious diseasesviral related diseases and disorders; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Compiling data for research purposes in the field of medical science and medical consultancy
Class 44
medical informational servicesproviding health information in the field of cancerinfectious diseasesviral related diseases and disorders via a global computer network; Providing medical information; Providing health information; Providing medical and health information related to cancerinfectious diseasesviral related diseases and disorders; Medical consulting services in the field of cancerinfectious diseasesviral related diseases and disorders
Publications
History of USPTO decisions and trademark events.
41 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/31/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/27/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/27/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/26/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/26/2024
IUAF
USE AMENDMENT FILED
08/22/2024
EISU
TEAS STATEMENT OF USE RECEIVED
08/22/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/24/2024
EX3G
SOU EXTENSION 3 GRANTED
02/23/2024
EXT3
SOU EXTENSION 3 FILED
02/23/2024
EEXT
SOU TEAS EXTENSION RECEIVED
02/23/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/25/2023
EX2G
SOU EXTENSION 2 GRANTED
08/23/2023
EXT2
SOU EXTENSION 2 FILED
08/23/2023
EEXT
SOU TEAS EXTENSION RECEIVED
08/23/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/25/2023
EX1G
SOU EXTENSION 1 GRANTED
02/23/2023
EXT1
SOU EXTENSION 1 FILED
02/23/2023
EEXT
SOU TEAS EXTENSION RECEIVED
02/23/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/15/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/15/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/15/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/23/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/28/2022
PUBO
PUBLISHED FOR OPPOSITION
06/28/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/08/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/21/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/06/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/06/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/19/2021
GNRT
NON-FINAL ACTION E-MAILED
11/19/2021
CNRT
NON-FINAL ACTION WRITTEN
11/19/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/19/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
10/19/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/19/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/19/2021
DOCK
ASSIGNED TO EXAMINER
09/13/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/20/2021
NWAP
NEW APPLICATION ENTERED
02/22/2021
Continuous trademark protection
Get notified about every new filing that threatens PINETREE THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.